# OnCo record icans-grading-and-management (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/icans-grading-and-management/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "icans-grading-and-management" ;
  schema:name "ICANS after CAR T-cell therapy: ICE score, ASTCT grading, steroids and seizure management"@en ;
  schema:alternateName "ICANS management"@en, "immune effector cell-associated neurotoxicity syndrome"@en, "ICE score"@en, "CAR-T neurotoxicity"@en, "CAPD score for children"@en ;
  schema:description "In the weeks after CAR T-cell therapy, some people become confused, struggle to find words or write, become very sleepy, or rarely have seizures. This is ICANS. Nurses check a short test of orientation, naming, writing and counting (the ICE score). Steroids such as dexamethasone treat it, and most people recover. A carer who notices confusion or odd speech should call the centre at once."@en ;
  schema:url <https://onco.cc/protocols/icans-grading-and-management/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t", "acute-oncology" ;
  onco:related <https://onco.cc/protocols/crs-grading-and-management/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/tocilizumab/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/brexucabtagene-autoleucel/>, <https://onco.cc/drugs/idecabtagene-vicleucel/>, <https://onco.cc/drugs/ciltacabtagene-autoleucel/>, <https://onco.cc/drugs/obecabtagene-autoleucel/> ;
  onco:institutions <https://onco.cc/institutions/sitc/> ;
  onco:terms <https://onco.cc/terms/icans/>, <https://onco.cc/terms/lymphoma-tx-crs-icans/> .
